CIK: 0001595851 · Show all filings
Period: Q4 2015 (← Previous) (Next →)
Filing Date: Feb 17, 2016
Total Value: $244M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| — | NUVASIVE INC | 230,000 | $12.45M | 5.1% | $54.11 | $46.62 | — | COM | 670704105 |
| AMGN | AMGEN INC | 75,000 | $12.18M | 5.0% | $162.33 * | $116.33 | +0.1% | COM | 031162100 |
| — | WRIGHT MED GROUP N V | 500,000 | $12.09M | 5.0% | $24.18 | $24.18 | — | ORD SHS 0.03 PAR | N96617118 |
| — | PORTOLA PHARMACEUTICALS INC | 230,000 | $11.83M | 4.8% | $51.45 | $48.90 | — | COM | 737010108 |
| — | SAGE THERAPEUTICS INC | 200,000 | $11.66M | 4.8% | $58.30 | $56.65 | — | COM | 78667J108 |
| — | SEATTLE GENETICS INC | 225,000 | $10.1M | 4.1% | $44.88 | $44.88 | — | COM | 812578102 |
| — | MALLINCKRODT PUB LTD CO | 135,000 | $10.07M | 4.1% | $74.63 | $65.13 | — | SHS | G5785G107 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 750,000 | $9.848M | 4.0% | $13.13 * | $8.97 | 0.0% | COM | 69404D108 |
| ACAD | ACADIA PHARMACEUTICALS INC | 250,000 | $8.913M | 3.6% | $35.65 | $35.23 | 0.0% | COM | 004225108 |
| IART | INTEGRA LIFESCIENCES HLDGS C | 120,000 | $8.134M | 3.3% | $67.78 * | $31.26 | -0.0% | COM NEW | 457985208 |
| — | MIRATI THERAPEUTICS INC | 250,000 | $7.9M | 3.2% | $31.60 | $31.60 | — | COM | 60468T105 |
| — | ZELTIQ AESTHETICS INC | 275,000 | $7.846M | 3.2% | $28.53 | $27.69 | — | COM | 98933Q108 |
| — | BLUEBIRD BIO INC | 120,000 | $7.706M | 3.2% | $64.22 | $64.22 | — | COM | 09609G100 |
| BIIB | BIOGEN INC | 25,000 | $7.659M | 3.1% | $306.36 * | $287.35 | 0.0% | COM | 09062X103 |
| — | SPECTRANETICS CORP | 435,000 | $6.551M | 2.7% | $15.06 | $13.18 | — | COM | 84760C107 |
| — | ACHILLION PHARMACEUTICALS IN | 600,000 | $6.474M | 2.7% | $10.79 | $8.85 | — | COM | 00448Q201 |
| PRTA | PROTHENA CORP PLC | 90,000 | $6.13M | 2.5% | $68.11 * | $60.32 | 0.0% | SHS | G72800108 |
| — | NANOSTRING TECHNOLOGIES INC | 400,000 | $5.884M | 2.4% | $14.71 | $13.25 | — | COM | 63009R109 |
| — | NEVRO CORP | 85,000 | $5.738M | 2.3% | $67.51 | $67.51 | — | COM | 64157F103 |
| INCY | INCYTE CORP | 50,000 | $5.423M | 2.2% | $108.46 * | $111.83 | -0.3% | COM | 45337C102 |
| — | DBV TECHNOLOGIES S A | 80,000 | $5.314M | 2.2% | $66.42 | $66.42 | — | SPONSORED ADR | 23306J101 |
| — | VITAE PHARMACEUTICALS INC | 275,000 | $4.978M | 2.0% | $18.10 | $12.29 | — | COM | 92847N103 |
| — | ACORDA THERAPEUTICS INC | 100,000 | $4.278M | 1.8% | $42.78 | $26.51 | — | COM | 00484M106 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 45,000 | $4.236M | 1.7% | $94.13 | $92.72 | 0.0% | COM | 02043Q107 |
| — | FIVE PRIME THERAPEUTICS INC | 100,000 | $4.15M | 1.7% | $41.50 | $23.02 | — | COM | 33830X104 |
| — | TANDEM DIABETES CARE INC | 350,000 | $4.134M | 1.7% | $11.81 | $11.81 | — | COM | 875372104 |
| SRPT | SAREPTA THERAPEUTICS INC | 100,000 | $3.858M | 1.6% | $38.58 * | $32.57 | -0.5% | COM | 803607100 |
| — | RETROPHIN INC | 200,000 | $3.858M | 1.6% | $19.29 | $19.29 | — | COM | 761299106 |
| — | SYNERGY PHARMACEUTICALS DEL | 600,000 | $3.402M | 1.4% | $5.67 | $5.30 | — | COM NEW | 871639308 |
| — | GENMARK DIAGNOSTICS INC | 410,000 | $3.182M | 1.3% | $7.76 | $9.06 | — | COM | 372309104 |
| — | ALCOBRA LTD | 500,000 | $3.14M | 1.3% | $6.28 | $5.68 | — | SHS | M2239P109 |
| — | TONIX PHARMACEUTICALS HLDG C | 350,000 | $2.685M | 1.1% | $7.67 | $7.16 | — | COM NEW | 890260201 |
| ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | 210,000 | $2.533M | 1.0% | $12.06 | $12.06 | — | SPONDS ADR | 00653A107 |
| — | ENTELLUS MED INC | 150,000 | $2.529M | 1.0% | $16.86 | $16.86 | — | COM | 29363K105 |
| VCYT | VERACYTE INC | 350,000 | $2.52M | 1.0% | $7.20 * | $8.42 | -20.0% | COM | 92337F107 |
| — | CYNAPSUS THERAPEUTICS INC | 151,630 | $2.318M | 0.9% | $15.29 | $16.29 | — | COM PAR NO PAR | 23257Y859 |
| PCRX | PACIRA PHARMACEUTICALS INC | 30,000 | $2.304M | 0.9% | $76.80 * | $61.25 | -7.6% | COM | 695127100 |
| — | CLOVIS ONCOLOGY INC | 50,000 | $1.75M | 0.7% | $35.00 | — | — | Call | 189464100 |
| LAB | FLUIDIGM CORP DEL | 150,000 | $1.622M | 0.7% | $10.81 * | $9.82 | 0.0% | COM | 34385P108 |
| — | DYNAVAX TECHNOLOGIES CORP | 55,000 | $1.329M | 0.5% | $24.16 | $24.16 | — | COM NEW | 268158201 |
| — | CORIUM INTL INC | 125,000 | $1.015M | 0.4% | $8.12 | $9.35 | — | COM | 21887L107 |
| RGNX | REGENXBIO INC | 60,000 | $996K | 0.4% | $16.60 * | $25.52 | -22.2% | COM | 75901B107 |
| FOLD | AMICUS THERAPEUTICS INC | 100,000 | $970K | 0.4% | $9.70 | — | — | Call | 03152W109 |
| CPRX | CATALYST PHARMACEUTICALS INC | 376,000 | $921K | 0.4% | $2.45 * | $4.22 | -32.1% | COM | 14888U101 |
| — | AKARI THERAPEUTICS PLC | 47,116 | $683K | 0.3% | $14.50 | $18.60 | — | SPONSORED ADR | 00972G108 |
| — | STRONGBRIDGE BIOPHARMA PLC | 72,726 | $553K | 0.2% | $7.60 | $7.60 | — | SHS USD | G85347105 |
| — | OCERA THERAPEUTICS INC | 125,000 | $390K | 0.2% | $3.12 | $10.04 | — | COM | 67552A108 |